In the present study, the in vitro cytotoxic effects of six semi-synthetic derivatives of elatol ( 1) and isoobtusol ( 2) were investigated. Chemical modifications were performed on the hydroxyl groups aiming to get derivatives of different polarity, namely the hemisuccinate, carbamate and sulfamate. The structural elucidation of the new derivatives was based on detailed NMR and MS spectroscopic analyses. The in vitro cytotoxicity of compounds 1 to 8 was evaluated against A459 and RD tumor cell lines with CC 50 values ranging from 4.93 to 41.53 μM. These results suggest that the structural modifications performed on both compounds could be considered a good strategy to obtain more active derivatives.
References
[1]
Mayer, A.M.; Rodríguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2005–6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim. Biophys. Acta 2009, 1790, 283–308.
Sims, J.J.; Lin, G.H.Y.; Wing, R.M. Marine natural products: Elatol, a halogenated sesquiterpene alcohol from the red alga Laurencia elata. Tetrahedron Lett. 1974, 39, 3487–3490.
[4]
K？nig, G.M.; Wright, A.D. Sesquiterpene content of the antibacterial dichlormethane extract of the red alga Laurencia obtusa. Planta Med. 1997, 63, 186–187, doi:10.1055/s-2006-957643.
[5]
Juagdan, E.G.; Kalidindi, R.; Scheuer, P. Two new chamigranes from an hawaiian red alga, Laurencia cartikzginea. Tetrahedron 1997, 2, 521–528.
[6]
Vairappan, C.S. Potent antibacterial activity of halogenated metabolites from Malaysian red algae, Laurencia majuscula (Rhodomelaceae, Ceramiales). Biomol. Eng. 2003, 20, 255–259, doi:10.1016/S1389-0344(03)00067-4.
[7]
Vairappan, C.S.; Anangdan, S.P.; Tan, K.L.; Matsunaga, S. Role of secondary metabolites as defense chemicals against ice-ice disease bacteria in biofouler at carrageenophyte farms. J. Appl. Phycol. 2009, 22, 305–311.
[8]
Lhullier, C.; Donnangelo, A.; Caro, M.; Palermo, J.A.; Horta, P.A.; Falkenberg, M.; Schenkel, E.P. Isolation of elatol from Laurencia microcladia and its palatability to the sea urchin Echinometra lucunter. Biochem. Syst. Ecol. 2009, 37, 254–259, doi:10.1016/j.bse.2009.04.004.
[9]
Granado, I.; Caballero, P. Chemical defense in the seaweed Laurencia obtusa (Hudson) Lamouroux. Sci. Mar. 1995, 59, 31–39.
[10]
De Nys, R.; Leya, T.; Maximilien, R.; Afsar, A.; Nair, P.S.R.; Steinberg, P.D. The need for standardised broad scale bioassay testing: A case study using the red alga Laurencia rigida. Biofouling 1996, 10, 213–224, doi:10.1080/08927019609386281.
[11]
Vairappan, C.S.; Daitoh, M.; Suzuki, M.; Abe, T.; Masuda, M. Antibacterial halogenated metabolites from the Malaysian Laurencia species. Phytochemistry 2001, 58, 291–297.
[12]
K？nig, G.M.; Wright, A.D. Laurencia rigida: Chemical investigations of its antifouling dichloromethane extract. J. Nat. Prod. 1997, 60, 967–970, doi:10.1021/np970181r.
[13]
Santos, A.O.; Veiga-Santos, P.; Ueda-Nakamura, T.; Dias-Filho, B.T.; Sudatti, D.B.; Bianco, E.M.; Nakamura, C.V. Effect of Elatol, Isolated from Red Seaweed Laurencia dendroidea, on Leishmania amazonensis. Mar. Drugs 2010, 8, 2733–2743, doi:10.3390/md8112733.
[14]
Veiga-Santos, P.; Pelizzaro-Rocha, K.J.; Santos, A.O.; Ueda-Nakamura, T.; Dias-Filho, B.T.; Silva, S.O.; Sudatti, D.B.; Bianco, E.M.; Nakamura, C.V. In vitro anti-trypanosomal activity of elatol isolated from red seaweed Laurencia dendroidea. Parasitology 2010, 137, 1661–1670, doi:10.1017/S003118201000034X.
[15]
Dias, T.; Brito, I.; Moujir, L.; Paiz, N.; Darias, J.; Cueto, M. Cytotoxic Sesquiterpenes from Aplysia dactylomela. J. Nat. Prod. 2005, 68, 1677–1679, doi:10.1021/np050240y.
[16]
Campos, A.; Souza, C.B.; Lhullier, C.; Schenkel, E.P.; Ribeiro-do-Valle, R.M.; Siqueira, J.M. Antitumoral effects of elatol, a marine derivative compound obtained from red algae Laurencia microcladia. J. Pharm. Pharmacol. 2012, 64, 1146–1154.
[17]
González, A.G.; Darias, J.; Díaz, A.; Fourneron, J.D.; Martín, J.D.; Pérez, C. Evidence for the biogenesis of halogenated chamigrenes from the red alga Laurencia obtusa. Tetrahedron Lett. 1976, 17, 3051–3054, doi:10.1016/0040-4039(76)80067-6.
[18]
Djuric, Z.; Heilbrun, L.K.; Lababidi, S.; Everett-Bauer, C.K.; Fariss, M.W. Growth inhibition of MCF-7 and MCF-10A human breast cells by α-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs. Cancer Lett. 1997, 111, 133–139, doi:10.1016/S0304-3835(96)04522-3.
[19]
Kogure, K.; Manabe, S.; Hama, S.; Tokumura, A.; Fukuzawa, K. Potentiation of anti-cancer effect by intravenous administration of vesiculated α-tocopheryl hemisuccinate on mouse melanoma in vivo. Cancer Lett. 2003, 192, 19–24, doi:10.1016/S0304-3835(02)00683-3.
[20]
Bandyopadhyay, P.; Janout, V.; Zhang, L.; Regen, S.L. Ion conductors derived from cholic acid and spermine: Importance of facial hydrophilicity on Na+ transport and membrane selectivity. J. Am. Chem. Soc. 2001, 123, 7691–7696, doi:10.1021/ja010926m.
[21]
Duran, F.J.; Ghini, A.A.; Dauban, P.; Dodd, R.H.; Burton, G. Synthesis of 6,19-sulfamidate bridged pregnanes. J. Org. Chem. 2005, 70, 8613–8616.
[22]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63, doi:10.1016/0022-1759(83)90303-4.
